Immune activation in multiple sclerosis: study of IL-2, sIL-2R, and gamma-IFN levels in serum and cerebrospinal fluid.
about
Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristicsIL-2 suppression of IL-12p70 by a recombinant HSV-1 expressing IL-2 induces T-cell auto-reactivity and CNS demyelinationUnexpected phenotype of mice lacking Shcbp1, a protein induced during T cell proliferation.IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production.Autoimmune disease and the nervous system. Biochemical, molecular, and clinical update.Correlation of interleukin-2 and soluble interleukin-2 receptor with clinical activity of multiple sclerosis.The association of -330 interleukin-2 gene polymorphism with its plasma concentration in Iranian multiple sclerosis patients.Suppression of IL-12p70 formation by IL-2 or following macrophage depletion causes T-cell autoreactivity leading to CNS demyelination in HSV-1-infected mice.Use of cytokine immunotherapy to block CNS demyelination induced by a recombinant HSV-1 expressing IL-2The association of -475 and -631 interleukin-2 gene polymorphism with multiple sclerosis in Iranian patients.Biomarkers of HIV related central nervous system disease.Role of interleukin-2 and herpes simplex virus 1 in central nervous system demyelination in miceGlatiramer acetate attenuates the activation of CD4+ T cells by modulating STAT1 and -3 signaling in glia.Soluble IL-2RA levels in multiple sclerosis subjects and the effect of soluble IL-2RA on immune responsesInflammatory biomarkers and spontaneous preterm birth among obese women.Induction of granzyme B and T cell cytotoxic capacity by IL-2 or IL-15 without antigens: multiclonal responses that are extremely lytic if triggered and short-lived after cytokine withdrawal.The soluble receptor of interleukin 2 is not a serum marker of the autoimmune activity in type I diabetes mellitus.
P2860
Q26998412-0B9D0A0C-7802-4CCE-A766-BCCE9B9F2B9CQ27437608-19298BD5-BA92-4EE7-A397-993E6671EE84Q28513010-3AD352F6-2D61-4809-86D2-7222A58D995CQ33396971-0D7EC595-4253-46E5-A339-9DB2FF38CDBCQ33560305-C238E7BD-40E5-4075-A6D0-3F47E8E0DE7CQ33590585-659D7404-4661-4532-A57E-FD97B5AE4C16Q33736320-515C16D6-ECC2-4896-9ED8-4C6225ECB1D4Q33758029-900FBE15-2E82-4480-8BFE-2F0861D7EABDQ35054374-5D409FB5-D4E1-4CBC-BE15-6D7BD63B5DE6Q37017274-2264DBBE-CF3E-4D2C-813C-5DDF64B1A602Q37073672-DE43DA40-652C-4D46-833F-8EB195ADFCF6Q37254368-926846C7-094D-4FCC-8144-3DFEB2F76669Q37589284-2D8D7DCF-B70D-40B9-AD25-8B49AF097EABQ37712459-42A373BC-FD60-4189-B1C0-507357028B6EQ41024413-F86373E2-D22C-44F3-9DD8-19B616C11B87Q42857041-BB981A5F-E09C-4276-85AA-03774D8DD71EQ43470740-A759BC80-5B63-4092-B03F-F85CE8B213FA
P2860
Immune activation in multiple sclerosis: study of IL-2, sIL-2R, and gamma-IFN levels in serum and cerebrospinal fluid.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Immune activation in multiple ...... serum and cerebrospinal fluid.
@en
type
label
Immune activation in multiple ...... serum and cerebrospinal fluid.
@en
prefLabel
Immune activation in multiple ...... serum and cerebrospinal fluid.
@en
P2093
P1476
Immune activation in multiple ...... serum and cerebrospinal fluid.
@en
P2093
Argentiero V
Giometto B
Piccinno MG
Tavolato B
P356
10.1016/0022-510X(89)90171-8
P577
1989-08-01T00:00:00Z